Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: The Business Research Company | PRODUCT CODE: 1509571

Cover Image

PUBLISHER: The Business Research Company | PRODUCT CODE: 1509571

Acoustic Neuroma Global Market Report 2024

PUBLISHED:
PAGES: 175 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
PDF (Single User License)
USD 5000
PDF (Site License)
USD 7500
PDF (Enterprise License)
USD 10000

Add to Cart

Acoustic neuroma, also known as vestibular schwannoma, is a benign tumor that develops on the vestibular nerve, linking the inner ear to the brain and responsible for transmitting balance and hearing information. These tumors typically progress slowly and remain confined to their original location, manifesting symptoms such as hearing loss, tinnitus (ringing in the ear), dizziness, imbalance, facial numbness or weakness, and coordination difficulties.

The primary types of acoustic neuroma include unilateral vestibular schwannomas and bilateral vestibular schwannomas. Unilateral vestibular schwannomas refer to tumors that develop on one side of the vestibulocochlear nerve, affecting both hearing and balance functions. Treatment options encompass medications, anticonvulsants, radiation therapy, proton therapy, and stereotactic radiosurgery. Diagnosis typically involves magnetic resonance imaging (MRI), computed tomography scan (CT-scan), and hearing tests. End users involved in the management of acoustic neuroma include hospitals, clinics, and surgical centers.

The acoustic neuroma market research report is one of a series of new reports from The Business Research Company that provides acoustic neuroma market statistics, including acoustic neuroma industry global market size, regional shares, competitors with a acoustic neuroma market share, detailed acoustic neuroma market segments, market trends and opportunities, and any further data you may need to thrive in the acoustic neuroma industry. This acoustic neuroma market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acoustic neuroma market size has grown strongly in recent years. It will grow from $1.70 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth observed in the historical period can be attributed to several factors, including advancements in imaging technologies, surgical innovations, increased awareness and screening programs for acoustic neuroma, economic factors influencing healthcare access, and regulatory approvals for treatment modalities.

The acoustic neuroma market size is expected to see strong growth in the next few years. It will grow to $2.52 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The forecast period's growth is expected to be driven by technological advancements in diagnostic and treatment approaches, the emergence of personalized medicine tailored to individual patient needs, increased healthcare spending globally, evolving patient preferences and demands for improved healthcare services, and ongoing development of healthcare infrastructure. Anticipated trends in the forecast period encompass rising incidence rates of acoustic neuroma, continuous technological innovations in diagnostic and treatment modalities, expansion of the market for acoustic neuroma treatments, collaborative research initiatives among healthcare stakeholders, and advancements in treatment modalities aimed at improving patient outcomes.

The surge in investment in the healthcare sector is anticipated to drive the growth of the acoustic neuroma market. The healthcare sector encompasses a broad range of services and facilities aimed at promoting health, providing medical care, and improving overall well-being for individuals and populations. Increased investment in healthcare is driven by various factors, including rising demand, technological innovation, regulatory changes, and global health challenges. These investments support advancements in diagnostics and treatments for conditions such as acoustic neuroma, ultimately enhancing patient outcomes and quality of life. For example, data from the Centers for Medicare & Medicaid Services (CMS) in December 2023 indicated a 4.1% increase in healthcare spending in the U.S. in 2022, reaching a total of $4.5 trillion. Consequently, the growing investment in the healthcare sector is fueling the expansion of the acoustic neuroma market.

Key players in the acoustic neuroma market are focusing on developing innovative treatment options, particularly radiosurgery methods tailored for acoustic neuroma patients, to offer enhanced features and benefits. Radiosurgery methods for acoustic neuroma involve precisely delivering radiation to the tumor to destroy or shrink it while minimizing damage to surrounding healthy tissue. For instance, Elekta, a Swedish-based medical technology company, introduced Elekta Esprit in May 2022, an advanced radiosurgery system designed for high-precision stereotactic radiosurgery targeting brain tumors, vascular malformations, or functional disorders. Elekta Esprit provides clinicians with faster automated treatment planning, enabling more personalized and patient-friendly treatments with exceptional precision. This advanced system offers superior visualization, remote accessibility, and collaboration tools, allowing treatment teams to address even the most challenging targets with exceptional accuracy while ensuring a gentle, personalized approach to radiosurgery.

In March 2021, Fujifilm Corporation, a Japan-based imaging and information solutions provider, acquired Hitachi Ltd.'s diagnostic imaging business for JPY 179 billion ($1.14 billion). This acquisition bolstered Fujifilm's medical systems business, including orthopedic imaging equipment, by incorporating Hitachi's diagnostic imaging-related business, covering CT, MRI, X-ray, and ultrasound systems, which also included diagnostic equipment for acoustic neuroma.

Major companies operating in the acoustic neuroma market are Pfizer Inc, F. Hoffmann-La Roche AG, General Electric Company, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GSK plc, Medtronic plc, Canon Medical Systems Corporation, Toshiba Medical Systems Corporation, Amgen Inc., Siemens Healthineers, Teva Pharmaceuticals Industries Ltd, Olympus Corporation, Shimadzu Corporation, Varian Medical Systems, Elekta AB, Cochlear Limited, Brainlab AG, Natus Medical Incorporated, CIVCO Medical Solutions, Monteris Medical, BrainScope Company Inc.

North America was the largest region in the acoustic neuroma market in 2023. The regions covered in the acoustic neuroma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the acoustic neuroma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acoustic neuroma market consists of revenues earned by entities by providing services such as neurosurgery, hearing tests, auditory rehabilitation, and counseling and support services for patients and families. The market value includes the value of related goods sold by the service provider or included within the service offering. The acoustic neuroma market also includes sales of hearing aids, surgical instruments, balance therapy equipment, and assistive listening devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acoustic Neuroma Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acoustic neuroma market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acoustic neuroma? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acoustic neuroma market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Unilateral Vestibular Schwannomas; Bilateral Vestibular Schwannomas
  • 2) By Treatment Type: Drugs; Anticonvulsants; Radiation Therapy; Proton Therapy; Stereotactic Radiosurgery
  • 3) Diagnosis Type: Magnetic Resonance Imaging (MRI); Computed Tomography Scan (CT-SCAN); Hearing Tests
  • 4) By End User: Hospitals; Clinics; Surgical Centers
  • Companies Mentioned: Pfizer Inc; F. Hoffmann-La Roche AG; General Electric Company; Merck & Co. Inc.; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.
Product Code: r18068

Table of Contents

1. Executive Summary

2. Acoustic Neuroma Market Characteristics

3. Acoustic Neuroma Market Trends And Strategies

4. Acoustic Neuroma Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Acoustic Neuroma Market Size and Growth

  • 5.1. Global Acoustic Neuroma Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Acoustic Neuroma Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Acoustic Neuroma Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Acoustic Neuroma Market Segmentation

  • 6.1. Global Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Unilateral Vestibular Schwannomas
  • Bilateral Vestibular Schwannomas
  • 6.2. Global Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drugs
  • Anticonvulsants
  • Radiation Therapy
  • Proton Therapy
  • Stereotactic Radiosurgery
  • 6.3. Global Acoustic Neuroma Market, Segmentation Diagnosis Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography Scan (CT-SCAN)
  • Hearing Tests
  • 6.4. Global Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Surgical Centers

7. Acoustic Neuroma Market Regional And Country Analysis

  • 7.1. Global Acoustic Neuroma Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Acoustic Neuroma Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Acoustic Neuroma Market

  • 8.1. Asia-Pacific Acoustic Neuroma Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Acoustic Neuroma Market

  • 9.1. China Acoustic Neuroma Market Overview
  • 9.2. China Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Acoustic Neuroma Market

  • 10.1. India Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Acoustic Neuroma Market

  • 11.1. Japan Acoustic Neuroma Market Overview
  • 11.2. Japan Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Acoustic Neuroma Market

  • 12.1. Australia Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Acoustic Neuroma Market

  • 13.1. Indonesia Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Acoustic Neuroma Market

  • 14.1. South Korea Acoustic Neuroma Market Overview
  • 14.2. South Korea Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Acoustic Neuroma Market

  • 15.1. Western Europe Acoustic Neuroma Market Overview
  • 15.2. Western Europe Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Acoustic Neuroma Market

  • 16.1. UK Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Acoustic Neuroma Market

  • 17.1. Germany Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Acoustic Neuroma Market

  • 18.1. France Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Acoustic Neuroma Market

  • 19.1. Italy Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Acoustic Neuroma Market

  • 20.1. Spain Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Acoustic Neuroma Market

  • 21.1. Eastern Europe Acoustic Neuroma Market Overview
  • 21.2. Eastern Europe Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Acoustic Neuroma Market

  • 22.1. Russia Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Acoustic Neuroma Market

  • 23.1. North America Acoustic Neuroma Market Overview
  • 23.2. North America Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Acoustic Neuroma Market

  • 24.1. USA Acoustic Neuroma Market Overview
  • 24.2. USA Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Acoustic Neuroma Market

  • 25.1. Canada Acoustic Neuroma Market Overview
  • 25.2. Canada Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Acoustic Neuroma Market

  • 26.1. South America Acoustic Neuroma Market Overview
  • 26.2. South America Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Acoustic Neuroma Market

  • 27.1. Brazil Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Acoustic Neuroma Market

  • 28.1. Middle East Acoustic Neuroma Market Overview
  • 28.2. Middle East Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Acoustic Neuroma Market

  • 29.1. Africa Acoustic Neuroma Market Overview
  • 29.2. Africa Acoustic Neuroma Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Acoustic Neuroma Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Acoustic Neuroma Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Acoustic Neuroma Market Competitive Landscape And Company Profiles

  • 30.1. Acoustic Neuroma Market Competitive Landscape
  • 30.2. Acoustic Neuroma Market Company Profiles
    • 30.2.1. Pfizer Inc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. General Electric Company
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck & Co. Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Sanofi S.A.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Acoustic Neuroma Market Other Major And Innovative Companies

  • 31.1. AstraZeneca plc
  • 31.2. Abbott Laboratories
  • 31.3. Novartis AG
  • 31.4. GSK plc
  • 31.5. Medtronic plc
  • 31.6. Canon Medical Systems Corporation
  • 31.7. Toshiba Medical Systems Corporation
  • 31.8. Amgen Inc.
  • 31.9. Siemens Healthineers
  • 31.10. Teva Pharmaceuticals Industries Ltd
  • 31.11. Olympus Corporation
  • 31.12. Shimadzu Corporation
  • 31.13. Varian Medical Systems
  • 31.14. Elekta AB
  • 31.15. Cochlear Limited

32. Global Acoustic Neuroma Market Competitive Benchmarking

33. Global Acoustic Neuroma Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Acoustic Neuroma Market

35. Acoustic Neuroma Market Future Outlook and Potential Analysis

  • 35.1 Acoustic Neuroma Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Acoustic Neuroma Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Acoustic Neuroma Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!